OGN — Organon & Co.
NYSE · Healthcare · Drug Manufacturers - General
Company fundamentals
| Metric | Cached value |
|---|---|
| Price (USD) | 13.8 |
| Market cap (USD) | 3,622,691,000 |
| P/E | 19.2 |
| ROE (%) | 29.87 |
| Net profit margin (%) | 3.03 |
| Revenue growth (%) | -2.92 |
| Dividend yield (%) | 0.58 |
Price last refreshed: .
Prices refreshed every 5 minutes during US market hours. Individual quotes may be older when provider data is missing or a refresh is incomplete. Check each quote's timestamp.
About Organon & Co.
Available company fundamentals for OGN in Drug Manufacturers - General. Values reflect cached source data, not live executable quotes. Valory Formula, when available, is informational analysis, not investment advice.